Department of Chemistry, University of Petroleum & Energy Studies, Dehradun, 248007, India.
Department of Chemistry, Uttaranchal University, Dehradun, 248007, India.
Chem Biol Interact. 2022 Sep 25;365:110048. doi: 10.1016/j.cbi.2022.110048. Epub 2022 Aug 4.
Mucus gel constitutes of heavily cross-linked mucin fibers forming a viscoelastic, dense porous network that coats all the exposed epithelia not covered with the skin. The layer provides protection to the underlying gastrointestinal, respiratory, and female reproductive tracts, in addition to the organs such as the surface of eye by trapping the pathogens, irritants, environmental fine particles, and potentially hazardous foreign matter. However, this property of mucus gel poses a substantial challenge for realizing the localized and sustained drug delivery across the mucosal surfaces. The mucus permeating particles that spare the protective properties of mucus gel improve the therapeutic potency of the drugs aimed at the management of diseases, including sexually transmitted infections, lung cancer, irritable bowel disease, degenerative eye diseases and infections, and cystic fibrosis. As such, the mucoadhesive materials conjugated with drug molecules display a prolonged retention time in the mucosal gel that imparts a sustained release of the deliberated drug molecules across the mucosa. The contemporarily developed mucus penetrating materials for drug delivery applications comprise of a finer size, appreciable hydrophilicity, and a neutral surface to escape the entrapment within the cross-inked mucus fibers. Pertaining to the mucus secretion as a first line of defence in respiratory tract in response to the invading physical, chemical, and biological pathogens, the development of mucus penetrating materials hold promise as a stalwart approach for revolutionizing the respiratory drug delivery paradigm. The present review provides an epigrammatic collation of the mucus penetrating/mucoadhesive materials for achieving a controlled/sustained release of the cargo pharmaceutics and drug molecules across the respiratory mucus barrier.
黏液凝胶由高度交联的黏蛋白纤维组成,形成一种黏弹性的、致密多孔的网络,覆盖所有未被皮肤覆盖的暴露上皮细胞。该层为胃肠道、呼吸道和女性生殖道等器官提供保护,此外还为眼睛表面等器官提供保护,防止病原体、刺激物、环境细颗粒物和潜在有害异物进入。然而,这种黏液凝胶的特性给实现黏膜表面局部和持续药物输送带来了巨大挑战。穿透黏液的颗粒可以避免黏液凝胶的保护特性,从而提高针对包括性传播感染、肺癌、肠易激综合征、退行性眼病和感染以及囊性纤维化等疾病管理的药物的治疗效果。因此,与药物分子结合的黏膜黏附材料在黏膜凝胶中的保留时间延长,从而使药物分子在黏膜上持续释放。目前开发的用于药物输送应用的穿透黏液材料具有更小的粒径、相当的亲水性和中性表面,以避免被困在交联的黏液纤维内。鉴于黏液分泌是呼吸道抵御入侵的物理、化学和生物病原体的第一道防线,穿透黏液材料的开发有望成为改变呼吸道药物输送模式的一种可靠方法。本综述简要概述了穿透黏液/黏膜黏附材料,以实现货物药物和药物分子在呼吸道黏液屏障中的控制/持续释放。